Journal article
Improving the Quality of Abstract Reporting for Phase I Cancer Trials
Abstract
PURPOSE: Conference abstracts of phase I trials (P1T) communicate important anticancer drug development information. Our objectives were to determine elements essential for good P1T abstract reporting, to assess the quality of P1T abstracts submitted to American Society of Clinical Oncology (ASCO) meetings, and to propose reporting guidelines.
EXPERIMENTAL DESIGN: A survey of developmental therapeutics experts established elements of P1T …
Authors
Strevel EL; Chau NG; Pond GR; Murgo AJ; Ivy PS; Siu LL
Journal
Clinical Cancer Research, Vol. 14, No. 6, pp. 1782–1787
Publisher
American Association for Cancer Research (AACR)
Publication Date
March 15, 2008
DOI
10.1158/1078-0432.ccr-07-4886
ISSN
1078-0432